Company intelligence / Profile preview

Lifemoot

London, England, United Kingdom

Ownership: Private
Employees: ~125
Development stage: Other

Overview

Lifebit's federated data platform enables secure access to distributed clinical and multi-omic datasets for biomedical research, drug development, and clinical trials. The technology is used by leading pharmaceutical companies, academic institutions, biobanks, and health systems globally to accelerate R&D through advanced data integration and analytics[2][3][5].

Therapeutic areas: Other
Modalities: Not applicable (Lifebit is a software/data platform company and does not develop therapeutics directly)
Industry: Drug Discovery Services

Partnerships

Boehringer IngelheimCancer Research Horizons/Cancer Research UKGenomics EnglandCanPath (Canadian Partnership for Tomorrow’s Health)Synapxe (Singapore)

Beyond the preview

Go deeper on Lifemoot.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lifemoot.

Explore the full profile